Viewing nowCombinationAis Staplus Tablet 80/5/5 mg (Telmisartan, Amlodipine, Rosuvastatin)
Telmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Intro Biopharma Co., Ltd.

MFDS item code 202500325 · Approved 2025.02.14
Treatment of dyslipidemia and hypertension; inhibition of atherosclerosis progression and reduction of cardiovascular disease risk
This medication is used in patients who require simultaneous administration of telmisartan and amlodipine combination and rosuvastatin. The telmisartan/amlodipine combination is effective when controlling blood pressure is difficult with monotherapy for essential hypertension. Rosuvastatin helps when cholesterol and triglyceride levels are not controlled by diet and exercise, delays the progression of atherosclerosis, and reduces the risk of cardiovascular disease. In particular, it may lower the risk of myocardial infarction, stroke, and arterial revascularization procedures. For these reasons, this medication is used together for blood pressure control and cardiovascular disease prevention.
Take 1 tablet once daily with water, regardless of meals. It is recommended that this medicine be taken at the same time each day, if possible (e.g., in the morning). This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the telmisartan/amlodipine combination and rosuvastatin. For patients taking telmisartan/amlodipine in combination with rosuvastatin as separate products, they may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. ○ Telmisartan/amlodipine combination Before starting telmisartan/amlodipine combination therapy, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with an individual component, switching directly to the telmisartan/amlodipine combination may be considered as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. - 80/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or this medicine 40/10 mg. ◦ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended that treatment be initiated at a low dose and the dose increased gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. ◦ Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of telmisartan should not exceed 40 mg. ◦ Elderly patients: In patients 75 years of age or older, amlodipine clearance is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually. ○ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with rosuvastatin and continue it throughout the treatment period. Rosuvastatin may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 mg once daily, which controls the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer, according to LDL cholesterol levels, treatment goals, and the patient's response; the dose may be increased to a maximum of 20 mg daily. 2. Elderly patients: No dose adjustment is required. 3. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not use in patients with severe renal impairment. Particular caution is required when administering rosuvastatin 20 mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or lower, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function tests should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer rosuvastatin to patients with active liver disease. 5. Race: Because systemic exposure to rosuvastatin is increased in Asian patients, the recommended starting dose is 5 mg. Administration of the 40 mg dose is contraindicated. 6. Patients predisposed to myopathy: The recommended starting dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of rosuvastatin is contraindicated in some of these patients. In a drug interaction study of the active ingredients of this medicine, telmisartan/amlodipine 80/10 mg and rosuvastatin 20 mg, rosuvastatin Cmax increased approximately 2.4-fold and AUC increased approximately 1.3-fold in the presence of telmisartan/amlodipine. Therefore, when administering this medicine, assess the potential risk associated with the increase in rosuvastatin Cmax and monitor patients closely.
This medication can cause serious harm to the fetus and newborn during pregnancy, so treatment should be promptly discontinued once pregnancy is confirmed. Patients with allergies to any components of this medication or similar components, or a history of specific angioedema should not take this medication. Administration is contraindicated in patients with severe liver or kidney impairment, severe heart disease, and certain specific conditions. Caution is advised for the elderly, patients with very low blood pressure, and those with mildly impaired liver function when taking this medication. If symptoms such as muscle pain, weakness, or cramps occur during treatment, consult a physician immediately and undergo muscle-related tests if necessary. Regular liver function tests and muscle enzyme tests are recommended while taking this medication. When taken with other medications, interactions may increase the effects or side effects of this medication, so inform your doctor or pharmacist of any other medications being taken. Women who may become pregnant should use proper contraceptive methods during treatment, and it is advisable not to take this medication while breastfeeding. This medication is not recommended for children under 18 years of age as its safety and efficacy have not been adequately established. In case of overdose, symptoms such as hypotension, dizziness, and irregular heartbeat may occur, and immediate medical attention should be sought if such symptoms arise. This medication should be kept out of reach of children and should not be transferred to another container.
Viral upper respiratory tract infection, dyspnea, anal hemorrhage, dyspepsia, atopic dermatitis, peripheral edema, chronic gastritis, various gastrointestinal disorders, hiatal hernia, dysuria, rhinitis, oropharyngeal discomfort, lung disease, unspecified intestinal disease, benign gastrointestinal neoplasm, hemorrhoids, skeletal pain, osteoporosis, sensory impairment, movement disorder, atherosclerosis, frequent urination, tinnitus, hearing loss, halitosis, fatty liver, headache, dizziness, orthostatic hypotension, back pain, edema, flushing, palpitations, fatigue, nausea, drowsiness, arrhythmia, bradycardia, chest pain, peripheral ischemia, syncope, vasculitis, peripheral neuropathy, tremors, loss of appetite, constipation, dysphagia, pancreatitis, vomiting, gingival hyperplasia, allergic reaction, burning sensation, malaise, pain, stiffness, weight gain, weight loss, erectile dysfunction, insomnia, neuroexcitability, depression, abnormal dreams, anxiety, depersonalization, angioedema, erythema multiforme, pruritus, rash, erythematous rash, papular rash, diplopia, eye pain, urinary disorders, nocturia, dry mouth, increased sweating, hyperglycemia, thirst, leukopenia, purpura, thrombocytopenia, angioedema, palpitations, dependent edema, angina, rapid pulse, leg edema, abnormal ECG, insomnia, drowsiness, migraine, sensory disturbances, involuntary muscle contractions, sensory impairment, flatulence, constipation, gastritis, vomiting, dry mouth, hemorrhoids, gastroenteritis, enteritis, gastroesophageal reflux, toothache, nonspecific gastrointestinal disease, gout, hypercholesterolemia, diabetes, arthritis, arthralgia, leg numbness, anxiety, depression, neuroexcitability, infection, fungal infection, abscess, otitis media, asthma, bronchitis, rhinitis, epistaxis, dermatitis, rash, eczema, pruritus, frequent urination, cystitis, cerebrovascular disease, visual disturbances, conjunctivitis, tinnitus, ear pain, angioedema, hypersensitivity reaction, fever, leg pain, malaise, headache, asthenia, cough, weakness, lower extremity edema, thrombocytopenia, increased uric acid, liver function abnormalities, liver disease, acute renal failure, anemia, elevated CPK, anaphylactic reaction, tendon pain, rhabdomyolysis, thrombocytopenia, jaundice, hepatitis, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, gynecomastia, depression, sleep disorders, interstitial lung disease, sexual dysfunction, jaundice, elevated liver enzyme levels, leukopenia, confusion, exfoliative dermatitis, photosensitivity reaction, toxic epidermal necrolysis, severe hypotension, reflex tachycardia, non-cardiogenic pulmonary edema, hypotension, tachycardia, bradycardia, acute renal failure, muscle cramps, myalgia, angioedema, thrombocytopenia, elevated serum creatinine, acute renal failure, oliguria, arthralgia, asthenia, numbness, sensory disturbances, chest discomfort, loss of appetite, abdominal distension, abnormal liver function tests, syncope, widespread pain, muscle cramps, gout, erectile dysfunction
Not everyone experiences these, and they can vary from person to person.
Store this medication in a container that can block light and air, and keep it at room temperature between 1 and 30 degrees Celsius. This way of storing will help maintain the efficacy of the medication.
Bright pink oval film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Intro Biopharma Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Telmisartan 80mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Il Dong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Telmisartan 80mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.